Winnie Yeo

TL;DR: Prophylactic lamivudine significantly reduces the incidence and morbidity of HBV reactivation in NPC patients undergoing chemotherapy.

TL;DR: During the course of a longitudinal study of HBsAg‐seropositive cancer patients who were monitored during standard chemotherapy, the opportunity was available to test the hypothesis that HBV reactivation may, indeed, have been the cause but thatHBV DNA levels became negative by the time ALT levels peaked and the clinical diagnosis of hepatitis was made.

TL;DR: The clinical course of reactivation in the two HBV‐infected sub‐populations, and the role of anti‐virals in the prevention and management of HBV reactivating in association with cytotoxic chemotherapy and biological therapies are discussed.

TL;DR: In this article, a cDNA microarray examination of the expression profiles of eight primary ovarian cancers was performed and the response of these patients to chemotherapy from their expression profiles was predicted using a voice-speech-pattern recognition algorithm.

TL;DR: Testing the effectiveness of an 8-week course of acupuncture in the management of chemotherapy-induced peripheral neuropathy in cancer patients who were receiving or had received neurotoxic chemotherapy found it to be an effective intervention.